SCHEMBL416333

SCHEMBL416333

CCCCC(C)CCC(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.66
ACE2 Q9BYF1 1/20 0.53
AKR1B1 P15121 1/20 0.52
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28308951 1.00 MAPT (0.66) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL13752139 1.00 MAPT (0.66) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL1199985 1.00 MAPT (0.66) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL28861210 0.98 MAPT (0.64) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL31099430 0.98 MAPT (0.64) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL19065142 0.98 MAPT (0.64) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL2727702 0.98 MAPT (0.64) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL2803203 0.96 MAPT (0.62) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL12970771 0.96 MAPT (0.62) MAPTACE2AKR1B1GPR84PPARG
SCHEMBL3117112 0.93 MAPT (0.64) MAPTACE2AKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026044024-A1 COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF I2O THERAPEUTICS, INC. (US) 2026-02-26 WO claimed
EP-4416250-B1 POLYAMIDE FUEL ADDITIVES CHEVRON USA INC (US) 2026-02-11 EP claimed
EP-4638676-A1 A FOAMABLE HARD SURFACE CLEANING COMPOSITION Unilever IP Holdings B.V. (NL) 2025-10-29 EP claimed
US-20250320174-A1 SPIN ON METAL-ORGANIC FORMULATIONS MERCK PATENTS GMBH (DE) 2025-10-16 US claimed
EP-4615958-A1 CELL COMPOSITIONS Givaudan SA (CH) 2025-09-17 EP claimed
EP-4583721-A1 COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2025-07-16 EP claimed
CN-119020084-B Water-resistant refrigerator oil and preparation method thereof 浙江康力博能源科技有限公司 2025-04-25 CN claimed
CN-119405039-A Roasted mutton flavor essence and preparation method and application thereof 江西省华宝孔雀食品科技发展有限公司 2025-02-11 CN claimed
CN-119372002-A Refrigerator oil and working fluid composition 珠海格力电器股份有限公司 2025-01-28 CN claimed
CN-119279156-A De-odorizing cured mutton and de-odorizing treatment process 中国农业大学 2025-01-10 CN claimed
EP-1024698-B1 PHEROMONE COMPOSITION KIOTECH LTD (GB) 2005-03-02 EP claimed
US-20030104023-A1 Natural insect repellant STRATACOR, INC. 2003-06-05 US claimed
US-20020009475-A1 Natural insect repellent STRATACOR, INC. (US) 2002-01-24 US claimed
EP-1018873-A4 NATURAL INSECT AND ARTHROPOD REPELLENT REIFENRATH WILLIAM G (US) 2001-02-07 EP claimed
EP-0715497-B1 FLAVOURING COMPOSITION AND PROCESS FIRMENICH & CIE (CH) 2000-10-04 EP claimed
EP-1018873-A1 NATURAL INSECT AND ARTHROPOD REPELLENT Reifenrath, William G. (US) 2000-07-19 EP claimed
WO-1999000014-A1 NATURAL INSECT AND ARTHROPOD REPELLENT REIFENRATH WILLIAM G (US) 1999-01-07 WO claimed
US-5695802-A ADDING TO FLAVORING INGREDIENT DIGLYCERIDE FRACTION OF HYDROLYZATE OF ANIMAL OR VEGETABLE FAT FIRMENICH SA (CH) 1997-12-09 US claimed
EP-0280443-B1 Improvements in or relating to repellent compositions DALGETY LTD (GB) 1994-04-20 EP claimed
EP-0280443-A2 Improvements in or relating to repellent compositions DALGETY U.K. LIMITED (GB) 1988-08-31 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320174-A1 SPIN ON METAL-ORGANIC FORMULATIONS SLC39A11, SLC39A3, SLC39A7 MAPT 128/4885ACE2 2841/4885AKR1B1 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.